RB1 c.2629T>C ;(p.F877L)

Variant ID: 13-49050945-T-C

NM_000321.2(RB1):c.2629T>C;(p.F877L)

This variant was identified in 40 publications

View GRCh38 version.




Publications:


Androgen Receptor Signaling Inhibition in Advanced Castration Resistance Prostate Cancer: What Is Expected for the Near Future?

Cancers
Pozas, Javier J; Álvarez Rodríguez, Sara S; Fernández, Víctor Albarrán VA; Burgos, Javier J; Santoni, Matteo M; Manneh Kopp, Ray R; Molina-Cerrillo, Javier J; Alonso-Gordoa, Teresa T
Publication Date: 2022-12-09

Variant appearance in text: RB1: F877L
PubMed Link: 36551557
Variant Present in the following documents:
  • Main text
  • cancers-14-06071.pdf
View BVdb publication page



Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer.

Cell Death & Disease
Chen, Xuanrong X; Shao, Yi Y; Wei, Wanqing W; Zhu, Shimiao S; Li, Yang Y; Chen, Yutong Y; Li, Hanling H; Tian, Hao H; Sun, Guijiang G; Niu, Yuanjie Y; Shang, Zhiqun Z
Publication Date: 2022-11-05

Variant appearance in text: RB1: F877L
PubMed Link: 36335093
Variant Present in the following documents:
  • 41419_2022_Article_5366.pdf
View BVdb publication page



Drug resistance in metastatic castration-resistant prostate cancer: an update on the status quo.

Cancer Drug Resistance (Alhambra, Calif.)
Yehya, Amani A; Ghamlouche, Fatima F; Zahwe, Amin A; Zeid, Yousef Y; Wakimian, Kevork K; Mukherji, Deborah D; Abou-Kheir, Wassim W
Publication Date: 2022

Variant appearance in text: RB1: F877L
PubMed Link: 36176747
Variant Present in the following documents:
  • cdr-5-3-667.pdf
View BVdb publication page



Second generation androgen receptor antagonists and challenges in prostate cancer treatment.

Cell Death & Disease
Chen, Yanhua Y; Zhou, Qianqian Q; Hankey, William W; Fang, Xiaosheng X; Yuan, Fuwen F
Publication Date: 2022-07-21

Variant appearance in text: RB1: F877L
PubMed Link: 35864113
Variant Present in the following documents:
  • Main text
  • 41419_2022_Article_5084.pdf
View BVdb publication page



Resistance to second generation antiandrogens in prostate cancer: pathways and mechanisms.

Cancer Drug Resistance (Alhambra, Calif.)
Verma, Shiv S; Prajapati, Kumari Sunita KS; Kushwaha, Prem Prakash PP; Shuaib, Mohd M; Kumar Singh, Atul A; Kumar, Shashank S; Gupta, Sanjay S
Publication Date: 2020

Variant appearance in text: RB1: F877L
PubMed Link: 35582225
Variant Present in the following documents:
  • cdr-3-742.pdf
View BVdb publication page



Prostate-Specific Membrane Antigen Expression and Response to DNA Damaging Agents in Prostate Cancer.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Sheehan, Beshara B; Neeb, Antje A; Buroni, Lorenzo L; Paschalis, Alec A; Riisnaes, Ruth R; Gurel, Bora B; Gil, Veronica V; Miranda, Susana S; Crespo, Mateus M; Guo, Christina C; Jiménez Vacas, Juan J; Figueiredo, Ines I; Ferreira, Ana A; Welti, Jon J; Yuan, Wei W; Carreira, Suzanne S; Sharp, Adam A; de Bono, Johann J
Publication Date: 2022-07-15

Variant appearance in text: RB1: F877L
PubMed Link: 35552383
Variant Present in the following documents:
  • 3104.pdf
View BVdb publication page



Clinical Applications of Liquid Biopsy in Prostate Cancer: From Screening to Predictive Biomarker.

Cancers
Ionescu, Filip F; Zhang, Jingsong J; Wang, Liang L
Publication Date: 2022-03-29

Variant appearance in text: RB1: F877L
PubMed Link: 35406500
Variant Present in the following documents:
  • Main text
  • cancers-14-01728.pdf
View BVdb publication page



The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology.

Nature Cancer
Tamborero, David D; Dienstmann, Rodrigo R; Rachid, Maan Haj MH; Boekel, Jorrit J; Lopez-Fernandez, Adria A; Jonsson, Markus M; Razzak, Ali A; Braña, Irene I; De Petris, Luigi L; Yachnin, Jeffrey J; Baird, Richard D RD; Loriot, Yohann Y; Massard, Christophe C; Martin-Romano, Patricia P; Opdam, Frans F; Schlenk, Richard F RF; Vernieri, Claudio C; Masucci, Michele M; Villalobos, Xenia X; Chavarria, Elena E; , ; Balmaña, Judith J; Apolone, Giovanni G; Caldas, Carlos C; Bergh, Jonas J; Ernberg, Ingemar I; Fröhling, Stefan S; Garralda, Elena E; Karlsson, Claes C; Tabernero, Josep J; Voest, Emile E; Rodon, Jordi J; Lehtiö, Janne J
Publication Date: 2022-02

Variant appearance in text: RB1: Phe877Leu
PubMed Link: 35221333
Variant Present in the following documents:
  • 43018_2022_332_MOESM3_ESM.xlsx, sheet 1
View BVdb publication page



Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies.

Cancers
Jacob, Aasems A; Raj, Rishi R; Allison, Derek B DB; Myint, Zin W ZW
Publication Date: 2021-10-28

Variant appearance in text: RB1: F877L
PubMed Link: 34771580
Variant Present in the following documents:
  • Main text
  • cancers-13-05417.pdf
View BVdb publication page



Molecular Characterization of Prostate Cancers in the Precision Medicine Era.

Cancers
Giunta, Emilio Francesco EF; Annaratone, Laura L; Bollito, Enrico E; Porpiglia, Francesco F; Cereda, Matteo M; Banna, Giuseppe Luigi GL; Mosca, Alessandra A; Marchiò, Caterina C; Rescigno, Pasquale P
Publication Date: 2021-09-24

Variant appearance in text: RB1: F877L
PubMed Link: 34638258
Variant Present in the following documents:
  • Main text
  • cancers-13-04771.pdf
View BVdb publication page



Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients.

Genome Medicine
Tsui, Dana W Y DWY; Cheng, Michael L ML; Shady, Maha M; Yang, Julie L JL; Stephens, Dennis D; Won, Helen H; Srinivasan, Preethi P; Huberman, Kety K; Meng, Fanli F; Jing, Xiaohong X; Patel, Juber J; Hasan, Maysun M; Johnson, Ian I; Gedvilaite, Erika E; Houck-Loomis, Brian B; Socci, Nicholas D ND; Selcuklu, S Duygu SD; Seshan, Venkatraman E VE; Zhang, Hongxin H; Chakravarty, Debyani D; Zehir, Ahmet A; Benayed, Ryma R; Arcila, Maria M; Ladanyi, Marc M; Funt, Samuel A SA; Feldman, Darren R DR; Li, Bob T BT; Razavi, Pedram P; Rosenberg, Jonathan J; Bajorin, Dean D; Iyer, Gopa G; Abida, Wassim W; Scher, Howard I HI; Rathkopf, Dana D; Viale, Agnes A; Berger, Michael F MF; Solit, David B DB
Publication Date: 2021-05-31

Variant appearance in text: RB1: F877L
PubMed Link: 34059130
Variant Present in the following documents:
  • 13073_2021_898_MOESM3_ESM.xlsx, sheet 1
View BVdb publication page



Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
McKay, Rana R RR; Kwak, Lucia L; Crowdis, Jett P JP; Sperger, Jamie M JM; Zhao, Shuang G SG; Xie, Wanling W; Werner, Lillian L; Lis, Rosina T RT; Zhang, Zhenwei Z; Wei, Xiao X XX; Lang, Joshua M JM; Van Allen, Eliezer M EM; Bhatt, Rupal S RS; Yu, Evan Y EY; Nelson, Peter S PS; Bubley, Glenn J GJ; Montgomery, R Bruce RB; Taplin, Mary-Ellen ME
Publication Date: 2021-07-01

Variant appearance in text: RB1: F877L
PubMed Link: 33849963
Variant Present in the following documents:
  • Main text
View BVdb publication page



Non-Coding RNAs Set a New Phenotypic Frontier in Prostate Cancer Metastasis and Resistance.

International Journal Of Molecular Sciences
Altschuler, Joshua J; Stockert, Jennifer A JA; Kyprianou, Natasha N
Publication Date: 2021-02-20

Variant appearance in text: RB1: F877L
PubMed Link: 33672595
Variant Present in the following documents:
  • Main text
  • ijms-22-02100.pdf
View BVdb publication page



Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors.

Jama Oncology
Cobain, Erin F EF; Wu, Yi-Mi YM; Vats, Pankaj P; Chugh, Rashmi R; Worden, Francis F; Smith, David C DC; Schuetze, Scott M SM; Zalupski, Mark M MM; Sahai, Vaibhav V; Alva, Ajjai A; Schott, Anne F AF; Caram, Megan E V MEV; Hayes, Daniel F DF; Stoffel, Elena M EM; Jacobs, Michelle F MF; Kumar-Sinha, Chandan C; Cao, Xuhong X; Wang, Rui R; Lucas, David D; Ning, Yu Y; Rabban, Erica E; Bell, Janice J; Camelo-Piragua, Sandra S; Udager, Aaron M AM; Cieslik, Marcin M; Lonigro, Robert J RJ; Kunju, Lakshmi P LP; Robinson, Dan R DR; Talpaz, Moshe M; Chinnaiyan, Arul M AM
Publication Date: 2021-04-01

Variant appearance in text: RB1: F877L
PubMed Link: 33630025
Variant Present in the following documents:
  • jamaoncol-e207987-s004.xlsx, sheet 2
View BVdb publication page



New Prognostic Biomarkers in Metastatic Castration-Resistant Prostate Cancer.

Cells
Conteduca, Vincenza V; Mosca, Alessandra A; Brighi, Nicole N; de Giorgi, Ugo U; Rescigno, Pasquale P
Publication Date: 2021-01-19

Variant appearance in text: RB1: F877L
PubMed Link: 33478015
Variant Present in the following documents:
  • Main text
  • cells-10-00193.pdf
View BVdb publication page



Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications.

Cells
Aurilio, Gaetano G; Cimadamore, Alessia A; Mazzucchelli, Roberta R; Lopez-Beltran, Antonio A; Verri, Elena E; Scarpelli, Marina M; Massari, Francesco F; Cheng, Liang L; Santoni, Matteo M; Montironi, Rodolfo R
Publication Date: 2020-12-10

Variant appearance in text: RB1: F877L
PubMed Link: 33321757
Variant Present in the following documents:
  • Main text
  • cells-09-02653.pdf
View BVdb publication page



Circulating cell-free nucleic acids as prognostic and therapy predictive tools for metastatic castrate-resistant prostate cancer.

World Journal Of Clinical Oncology
Sobhani, Navid N; Sirico, Marianna M; Generali, Daniele D; Zanconati, Fabrizio F; Scaggiante, Bruna B
Publication Date: 2020-07-24

Variant appearance in text: RB1: F877L
PubMed Link: 32821651
Variant Present in the following documents:
  • Main text
View BVdb publication page



Dynamics of Cellular Plasticity in Prostate Cancer Progression.

Frontiers In Molecular Biosciences
Tiwari, Ritika R; Manzar, Nishat N; Ateeq, Bushra B
Publication Date: 2020

Variant appearance in text: RB1: F877L
PubMed Link: 32754615
Variant Present in the following documents:
  • Main text
  • fmolb-07-00130.pdf
View BVdb publication page



Prostate cancer biology & genomics.

Translational Andrology And Urology
Whitaker, Hayley H; Tam, Joseph O JO; Connor, Martin J MJ; Grey, Alistair A
Publication Date: 2020-06

Variant appearance in text: RB1: F877L
PubMed Link: 32676435
Variant Present in the following documents:
  • Main text
  • tau-09-03-1481.pdf
View BVdb publication page



Clinical Applications of Molecular Biomarkers in Prostate Cancer.

Cancers
Couñago, Felipe F; López-Campos, Fernando F; Díaz-Gavela, Ana Aurora AA; Almagro, Elena E; Fenández-Pascual, Esaú E; Henríquez, Iván I; Lozano, Rebeca R; Linares Espinós, Estefanía E; Gómez-Iturriaga, Alfonso A; de Velasco, Guillermo G; Quintana Franco, Luis Miguel LM; Rodríguez-Melcón, Ignacio I; López-Torrecilla, José J; Spratt, Daniel E DE; Guerrero, Luis Leonardo LL; Martínez-Salamanca, Juan Ignacio JI; Del Cerro, Elia E
Publication Date: 2020-06-12

Variant appearance in text: RB1: F877L
PubMed Link: 32545454
Variant Present in the following documents:
  • cancers-12-01550.pdf
View BVdb publication page



Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation.

Cancer Cell
Zhang, Zeda Z; Zhou, Chuanli C; Li, Xiaoling X; Barnes, Spencer D SD; Deng, Su S; Hoover, Elizabeth E; Chen, Chi-Chao CC; Lee, Young Sun YS; Zhang, Yanxiao Y; Wang, Choushi C; Metang, Lauren A LA; Wu, Chao C; Tirado, Carla Rodriguez CR; Johnson, Nickolas A NA; Wongvipat, John J; Navrazhina, Kristina K; Cao, Zhen Z; Choi, Danielle D; Huang, Chun-Hao CH; Linton, Eliot E; Chen, Xiaoping X; Liang, Yupu Y; Mason, Christopher E CE; de Stanchina, Elisa E; Abida, Wassim W; Lujambio, Amaia A; Li, Sheng S; Lowe, Scott W SW; Mendell, Joshua T JT; Malladi, Venkat S VS; Sawyers, Charles L CL; Mu, Ping P
Publication Date: 2020-04-13

Variant appearance in text: RB1: F877L
PubMed Link: 32220301
Variant Present in the following documents:
  • Main text
  • mmc8.pdf
View BVdb publication page



Androgen deprivation upregulates SPINK1 expression and potentiates cellular plasticity in prostate cancer.

Nature Communications
Tiwari, Ritika R; Manzar, Nishat N; Bhatia, Vipul V; Yadav, Anjali A; Nengroo, Mushtaq A MA; Datta, Dipak D; Carskadon, Shannon S; Gupta, Nilesh N; Sigouros, Michael M; Khani, Francesca F; Poutanen, Matti M; Zoubeidi, Amina A; Beltran, Himisha H; Palanisamy, Nallasivam N; Ateeq, Bushra B
Publication Date: 2020-01-20

Variant appearance in text: RB1: F877L
PubMed Link: 31959826
Variant Present in the following documents:
  • Main text
  • 41467_2019_Article_14184.pdf
View BVdb publication page



Genomics of lethal prostate cancer at diagnosis and castration resistance.

The Journal Of Clinical Investigation
Mateo, Joaquin J; Seed, George G; Bertan, Claudia C; Rescigno, Pasquale P; Dolling, David D; Figueiredo, Ines I; Miranda, Susana S; Nava Rodrigues, Daniel D; Gurel, Bora B; Clarke, Matthew M; Atkin, Mark M; Chandler, Rob R; Messina, Carlo C; Sumanasuriya, Semini S; Bianchini, Diletta D; Barrero, Maialen M; Petermolo, Antonella A; Zafeiriou, Zafeiris Z; Fontes, Mariane M; Perez-Lopez, Raquel R; Tunariu, Nina N; Fulton, Ben B; Jones, Robert R; McGovern, Ursula U; Ralph, Christy C; Varughese, Mohini M; Parikh, Omi O; Jain, Suneil S; Elliott, Tony T; Sandhu, Shahneen S; Porta, Nuria N; Hall, Emma E; Yuan, Wei W; Carreira, Suzanne S; de Bono, Johann S JS
Publication Date: 2020-04-01

Variant appearance in text: RB1: 2629T>C; F877L
PubMed Link: 31874108
Variant Present in the following documents:
  • jci-130-132031-s102.xlsx, sheet 2
View BVdb publication page



Plasma Androgen Receptor in Prostate Cancer.

Cancers
Conteduca, Vincenza V; Gurioli, Giorgia G; Brighi, Nicole N; Lolli, Cristian C; Schepisi, Giuseppe G; Casadei, Chiara C; Burgio, Salvatore Luca SL; Gargiulo, Stefania S; Ravaglia, Giorgia G; Rossi, Lorena L; Altavilla, Amelia A; Farolfi, Alberto A; Menna, Cecilia C; Colangione, Sarah Pia SP; Pulvirenti, Mario M; Romeo, Antonino A; De Giorgi, Ugo U
Publication Date: 2019-11-04

Variant appearance in text: RB1: F877L
PubMed Link: 31689899
Variant Present in the following documents:
  • Main text
  • cancers-11-01719.pdf
View BVdb publication page



Molecular Testing in Patients With Castration-Resistant Prostate Cancer and Its Impact on Clinical Decision Making.

Jco Precision Oncology
Tao, Derrick L DL; Bailey, Shawna S; Beer, Tomasz M TM; Foss, Erik E; Beckett, Brooke B; Fung, Alice A; Foster, Bryan R BR; Guimaraes, Alexander A; Cetnar, Jeremy P JP; Graff, Julie N JN; Eilers, Kristine M KM; Small, Eric J EJ; Corless, Christopher L CL; Thomas, George V GV; Alumkal, Joshi J JJ
Publication Date: 2017

Variant appearance in text: N/A
PubMed Link: 31650098
Variant Present in the following documents:
View BVdb publication page



Towards precision oncology in advanced prostate cancer.

Nature Reviews. Urology
Ku, Sheng-Yu SY; Gleave, Martin E ME; Beltran, Himisha H
Publication Date: 2019-11

Variant appearance in text: N/A
PubMed Link: 31591549
Variant Present in the following documents:
View BVdb publication page



Drivers of AR indifferent anti-androgen resistance in prostate cancer cells.

Scientific Reports
Handle, Florian F; Prekovic, Stefan S; Helsen, Christine C; Van den Broeck, Thomas T; Smeets, Elien E; Moris, Lisa L; Eerlings, Roy R; Kharraz, Sarah El SE; Urbanucci, Alfonso A; Mills, Ian G IG; Joniau, Steven S; Attard, Gerhardt G; Claessens, Frank F
Publication Date: 2019-09-24

Variant appearance in text: RB1: F877L
PubMed Link: 31551480
Variant Present in the following documents:
  • 41598_2019_Article_50220.pdf
View BVdb publication page



Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications.

Medicines (Basel, Switzerland)
Testa, Ugo U; Castelli, Germana G; Pelosi, Elvira E
Publication Date: 2019-07-30

Variant appearance in text: RB1: F877L
PubMed Link: 31366128
Variant Present in the following documents:
  • Main text
  • medicines-06-00082.pdf
View BVdb publication page



Prospective Comprehensive Genomic Profiling of Primary and Metastatic Prostate Tumors.

Jco Precision Oncology
Chung, Jon H JH; Dewal, Ninad N; Sokol, Ethan E; Mathew, Paul P; Whitehead, Robert R; Millis, Sherri Z SZ; Frampton, Garrett M GM; Bratslavsky, Gennady G; Pal, Sumanta K SK; Lee, Richard J RJ; Necchi, Andrea A; Gregg, Jeffrey P JP; Lara, Primo P; Antonarakis, Emmanuel S ES; Miller, Vincent A VA; Ross, Jeffrey S JS; Ali, Siraj M SM; Agarwal, Neeraj N
Publication Date: 2019

Variant appearance in text: RB1: F877L
PubMed Link: 31218271
Variant Present in the following documents:
  • PO.18.00283.pdf
View BVdb publication page



Circulating tumor DNA in advanced prostate cancer: transitioning from discovery to a clinically implemented test.

Prostate Cancer And Prostatic Diseases
González-Billalabeitia, Enrique E; Conteduca, Vincenza V; Wetterskog, Daniel D; Jayaram, Anuradha A; Attard, Gerhardt G
Publication Date: 2019-05

Variant appearance in text: RB1: 2629T>C; F877L
PubMed Link: 30413805
Variant Present in the following documents:
  • Main text
  • emss-79467.pdf
View BVdb publication page



Castration-Resistant Prostate Cancer Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents: Opportunities and Challenges.

Cancers
Kita, Yuki Y; Goto, Takayuki T; Akamatsu, Shusuke S; Yamasaki, Toshinari T; Inoue, Takahiro T; Ogawa, Osamu O; Kobayashi, Takashi T
Publication Date: 2018-09-21

Variant appearance in text: RB1: F877L
PubMed Link: 30248934
Variant Present in the following documents:
  • Main text
  • cancers-10-00345.pdf
View BVdb publication page



Liquid biopsy approach in the management of prostate cancer.

Translational Research : The Journal Of Laboratory And Clinical Medicine
Riaz, Irbaz Bin IB; Wang, Liang L; Kohli, Manish M
Publication Date: 2018-11

Variant appearance in text: N/A
PubMed Link: 29936077
Variant Present in the following documents:
View BVdb publication page



Mechanisms and Approaches for Overcoming Enzalutamide Resistance in Prostate Cancer.

Frontiers In Oncology
Vander Ark, Alexandra A; Cao, Jingchen J; Li, Xiaohong X
Publication Date: 2018

Variant appearance in text: RB1: F877L
PubMed Link: 29911070
Variant Present in the following documents:
  • Main text
  • fonc-08-00180.pdf
View BVdb publication page



From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards.

Genome Medicine
Perera-Bel, Júlia J; Hutter, Barbara B; Heining, Christoph C; Bleckmann, Annalen A; Fröhlich, Martina M; Fröhling, Stefan S; Glimm, Hanno H; Brors, Benedikt B; Beißbarth, Tim T
Publication Date: 2018-03-15

Variant appearance in text: RB1: F877L
PubMed Link: 29544535
Variant Present in the following documents:
  • 13073_2018_529_MOESM5_ESM.pdf
View BVdb publication page



Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making.

Jco Precision Oncology
Abida, Wassim W; Armenia, Joshua J; Gopalan, Anuradha A; Brennan, Ryan R; Walsh, Michael M; Barron, David D; Danila, Daniel D; Rathkopf, Dana D; Morris, Michael M; Slovin, Susan S; McLaughlin, Brigit B; Curtis, Kristen K; Hyman, David M DM; Durack, Jeremy C JC; Solomon, Stephen B SB; Arcila, Maria E ME; Zehir, Ahmet A; Syed, Aijazuddin A; Gao, Jianjiong J; Chakravarty, Debyani D; Vargas, Hebert Alberto HA; Robson, Mark E ME; Joseph, Vijai V; Offit, Kenneth K; Donoghue, Mark T A MTA; Abeshouse, Adam A AA; Kundra, Ritika R; Heins, Zachary J ZJ; Penson, Alexander V AV; Harris, Christopher C; Taylor, Barry S BS; Ladanyi, Marc M; Mandelker, Diana D; Zhang, Liying L; Reuter, Victor E VE; Kantoff, Philip W PW; Solit, David B DB; Berger, Michael F MF; Sawyers, Charles L CL; Schultz, Nikolaus N; Scher, Howard I HI
Publication Date: 2017-07

Variant appearance in text: RB1: F877L
PubMed Link: 28825054
Variant Present in the following documents:
  • Main text
View BVdb publication page



Androgen Receptor-Dependent and -Independent Mechanisms Involved in Prostate Cancer Therapy Resistance.

Cancers
Crona, Daniel J DJ; Whang, Young E YE
Publication Date: 2017-06-12

Variant appearance in text: RB1: F877L
PubMed Link: 28604629
Variant Present in the following documents:
  • Main text
  • cancers-09-00067.pdf
View BVdb publication page



Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles.

Oncotarget
Hoang, David T DT; Iczkowski, Kenneth A KA; Kilari, Deepak D; See, William W; Nevalainen, Marja T MT
Publication Date: 2017-01-10

Variant appearance in text: RB1: F877L
PubMed Link: 27741508
Variant Present in the following documents:
  • Main text
  • oncotarget-08-3724.pdf
View BVdb publication page



Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate Cancer.

Jama Oncology
Wyatt, Alexander W AW; Azad, Arun A AA; Volik, Stanislav V SV; Annala, Matti M; Beja, Kevin K; McConeghy, Brian B; Haegert, Anne A; Warner, Evan W EW; Mo, Fan F; Brahmbhatt, Sonal S; Shukin, Robert R; Le Bihan, Stephane S; Gleave, Martin E ME; Nykter, Matti M; Collins, Colin C CC; Chi, Kim N KN
Publication Date: 2016-12-01

Variant appearance in text: RB1: F877L
PubMed Link: 27148695
Variant Present in the following documents:
  • Main text
View BVdb publication page



Novel Insights into Molecular Indicators of Response and Resistance to Modern Androgen-Axis Therapies in Prostate Cancer.

Current Urology Reports
Silberstein, John L JL; Taylor, Maritza N MN; Antonarakis, Emmanuel S ES
Publication Date: 2016-04

Variant appearance in text: RB1: F877L
PubMed Link: 26902623
Variant Present in the following documents:
  • Main text
View BVdb publication page



Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer.

Nature Reviews. Cancer
Watson, Philip A PA; Arora, Vivek K VK; Sawyers, Charles L CL
Publication Date: 2015-12

Variant appearance in text: RB1: F877L
PubMed Link: 26563462
Variant Present in the following documents:
  • Main text
View BVdb publication page